tiprankstipranks
Trending News
More News >
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market

XORTX Therapeutics Inc (XRTX) Financial Statements

Compare
79 Followers

XORTX Therapeutics Inc Financial Overview

XORTX Therapeutics Inc's market cap is currently $3.46M. The company's EPS TTM is $-0.13; its P/E ratio is -1.04; XORTX Therapeutics Inc is scheduled to report earnings on November 15, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -160.66K-C$ -75.27KC$ -17.88KC$ -20.44K
Operating IncomeC$ -5.64M-C$ -12.43M-C$ -1.08M
EBITDAC$ -4.38M-C$ -9.41M-C$ -1.25M
Net IncomeC$ -4.54M--C$ -1.65MC$ -1.28M
Balance Sheet
Cash & Short-Term InvestmentsC$ 3.56MC$ 3.45MC$ 10.43MC$ 14.79MC$ 171.27K
Total AssetsC$ 5.89MC$ 5.47MC$ 12.37MC$ 17.38MC$ 2.29M
Total DebtC$ 55.78KC$ 11.51KC$ 77.60KC$ 0.00C$ 0.00
Net DebtC$ -3.50MC$ -3.44MC$ -10.36MC$ -14.87MC$ -171.27K
Total LiabilitiesC$ 1.09MC$ 825.94KC$ 5.38MC$ 4.18MC$ 1.03M
Stockholders' EquityC$ 4.80MC$ 4.64MC$ 7.00MC$ 13.20MC$ 1.26M
Cash Flow
Free Cash FlowC$ -5.04MC$ -6.63MC$ -9.01MC$ -4.83MC$ -742.75K
Operating Cash FlowC$ -5.04MC$ -6.58MC$ -8.96MC$ -4.80MC$ -728.40K
Investing Cash FlowC$ -53.32KC$ -46.36KC$ -45.70KC$ -31.81KC$ -14.35K
Financing Cash FlowC$ 3.81MC$ -487.30KC$ 4.71MC$ 19.37MC$ 670.82K
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

XORTX Therapeutics Inc Debt to Assets

XORTX Therapeutics Inc Cash Flow

XORTX Therapeutics Inc Forecast EPS vs Actual EPS